Abiopharma

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

Philips IR alert | Fourth quarter and Full-year 2025 results publication

Natera - Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer

Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

Novartis breaks ground on flagship manufacturing hub in North Carolina

Castle Biosciences - Systematic Review and Meta-Analysis ConfirmsTissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer